2. Maximum methaemoglobin percentages reported in each trial with tafenoquine 300 mg single dose and standard‐dose primaquine.
Trial | Drug | Maximum methaemoglobin percentage |
Lacerda 2019 | TQ PQ |
13% 14.7% |
Llanos‐Cuentas 2014 | TQ | Not reported for TQ 300 mg group |
Llanos‐Cuentas 2019 | TQ PQ |
1.9% 4.1% |
PQ: primaquine; TQ: tafenoquine.